On December 29, 2014, Richard Kent informed the company of his resignation from the board of directors of Nuo Therapeutics, Inc. with the effective date of his departure of December 31, 2014. Mr. Kent was an independent member of the board and a member of the board's Compensation Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | +1.35% | 0.00% | +36.36% |
05-20 | Nuo Therapeutics, Inc. announced that it has received $0.650875 million in funding | CI |
05-15 | Nuo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+36.36% | 33.83M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- AURX Stock
- News Nuo Therapeutics, Inc.
- Nuo Therapeutics, Inc. Announces Resignation of Richard Kent from the Board of Directors